Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer

This document is a response to comments for the MolDX Local Coverage Determination L38576 on prognostic and predictive molecular classifiers for bladder cancer. The comment period ran 06/23/2022–08/06/2022; the notice period begins 06/22/2023 and the LCD becomes effective 08/06/2023. No clinical coverage criteria, indications, limitations, documentation requirements, or frequency limits are specified in this response notice.